Correlation Between Phio Pharmaceuticals and Immix Biopharma

Can any of the company-specific risk be diversified away by investing in both Phio Pharmaceuticals and Immix Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phio Pharmaceuticals and Immix Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Phio Pharmaceuticals Corp and Immix Biopharma, you can compare the effects of market volatilities on Phio Pharmaceuticals and Immix Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phio Pharmaceuticals with a short position of Immix Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phio Pharmaceuticals and Immix Biopharma.

Diversification Opportunities for Phio Pharmaceuticals and Immix Biopharma

-0.14

Correlation Coefficient

Phio Pharmaceuticals  Immix Biopharma

Good diversification

The 3 months correlation between Phio and Immix is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Phio Pharmaceuticals Corp and Immix Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immix Biopharma and Phio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phio Pharmaceuticals Corp are associated (or correlated) with Immix Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immix Biopharma has no effect on the direction of Phio Pharmaceuticals i.e., Phio Pharmaceuticals and Immix Biopharma go up and down completely randomly.

Pair Corralation between Phio Pharmaceuticals and Immix Biopharma

Given the investment horizon of 90 days Phio Pharmaceuticals Corp is expected to under-perform the Immix Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Phio Pharmaceuticals Corp is 1.14 times less risky than Immix Biopharma. The stock trades about -0.15 of its potential returns per unit of risk. The Immix Biopharma is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  171.00  in Immix Biopharma on August 30, 2024 and sell it today you would earn a total of  26.00  from holding Immix Biopharma or generate 15.2% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Phio Pharmaceuticals Corp  vs.  Immix Biopharma

Phio Pharmaceuticals Corp

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Phio Pharmaceuticals Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Phio Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Immix Biopharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Immix Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong primary indicators, Immix Biopharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Phio Pharmaceuticals and Immix Biopharma

The main advantage of trading using opposite Phio Pharmaceuticals and Immix Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phio Pharmaceuticals position performs unexpectedly, Immix Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immix Biopharma will offset losses from the drop in Immix Biopharma's long position.

The idea behind Phio Pharmaceuticals Corp and Immix Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.